Ribonovix Inc - MA Middlesex, Lincoln 01773

Ribonovix Inc entered the industry of Commercial Biotechnical Research in 2003 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 541711, which describes it as a Commercial Biotechnical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Biotechnical Research. The business provides service to the B2B market.

To acquire more information, please contact Alison Taunton-Rigby by calling No number given during business hours. You can also write to the business’ Single Location at 8 Farrar Road, Lincoln, Massachusetts MA 01773. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Ribonovix Inc
Representative: Alison Taunton-Rigby
Place of Business: 8 Farrar Road, Lincoln, MA 01773
Contact Number: No number given
Type of Service: Commercial Biotechnical Research
SIC Number: 8731
NAICS Number: 541711
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 2003
Income/Year: $100.000 to $499.999
Laborers: 1 to 4
Share This Company:

Ribonovix Inc is a company operating from Middlesex, Massachusetts providing professional Commercial Biotechnical Research and relevant B2B variables. It was founded in 2003 and registered with the SIC code 8731 as Commercial Biotechnical Research, and with the NAICS code 541711 as Commercial Biotechnical Research.

With a current employee count of 1 to 4, Ribonovix Inc has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Alison Taunton-Rigby at No number given for related queries, or to locate its Single Location using the coordinates .

The Single Location can also be found at the street address 8 Farrar Road in Lincoln, Massachusetts 01773 and can be engaged online through the company website at , the company Twitter , and Facebook page .